Follow-up of 452 totally implantable vascular devices in cystic fibrosis patients Source: Eur Respir J 2004; 23: 430-434 Year: 2004
Complications of a permanently implanted port system for continuous epoprostenol treatment in pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 597s Year: 2002
Experience with totally implantable venous access devices in cystic fibrosis patients Source: Eur Respir J 2003; 22: Suppl. 45, 502s Year: 2003
Spontaneous flow increase from implantable pump for intravenous treprostinil delivery Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016
Broviac catheter complications of intravenous epoprostenol therapy in patients with pulmonary arterial hypertension Source: Eur Respir J 2004; 24: Suppl. 48, 636s Year: 2004
Our experience in natural surfactant administration for prevention of respiratory failure after cardiac surgery procedures Source: Eur Respir J 2004; 24: Suppl. 48, 205s Year: 2004
Candidaemia in cystic fibrosis patients with totally implantable venous access devices is associated with invasive procedures and exacerbation frequency Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment Year: 2015
Intravenous line complications during continuous iloprost therapy using directly inserted subclavian catheters Source: Annual Congress 2009 - Pulmonary circulation II Year: 2009
Prolonged anticoagulation in VTE with direct oral anticoagulants: towards an individual analysis of net clinical benefit? Source: Eur Respir J 2016; 48: 1268-1270 Year: 2016
Procedural safety of a fully implantable pump for delivery of intravenous prostanoids in severe pulmonary hypertension: A two-center observational study Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016
Totally implantable venous access devices in patients with cystic fibrosis Source: Annual Congress 2008 - Cystic fibrosis: a disease with many aspects Year: 2008
Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk pulmonary embolism secondary to a major transient/reversible risk factor? Source: Eur Respir J, 55 (1) 1902028; 10.1183/13993003.02028-2019 Year: 2020
Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk pulmonary embolism secondary to a major transient/reversible risk factor? Source: Eur Respir J, 55 (1) 1902323; 10.1183/13993003.02323-2019 Year: 2020
Which patients with COPD can potentially benefit from prophylactic use of antibiotics? Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007
Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD? Source: Eur Respir J, 54 (4) 1901405; 10.1183/13993003.01405-2019 Year: 2019
Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD? Source: Eur Respir J, 54 (4) 1901597; 10.1183/13993003.01597-2019 Year: 2019
Co-morbidities and cardiovascular medications are the best predictors of mortality in patients with obesity-associated hypoventilation treated with long-term non-invasive ventilation Source: Annual Congress 2012 - Current trends in home mechanical ventilation Year: 2012
Hypnotics did not worsen a prognosis of patients receiving long-term oxygen and/or noninvasive ventilation Source: International Congress 2017 – Clinical and physiological challenges in noninvasive ventilation Year: 2017
Risk factors of reintubation in patients receiving post-extubation nasal high flow therapy Source: Virtual Congress 2020 – Novel findings regarding acute respiratory distress syndrome, extra corporeal membrane oxygenation and weaning from mechanical ventilation Year: 2020
Advantages of CPAPn therapy in OSAS patients with cardiac rhythm complications Source: Annual Congress 2010 - Complex sleep apnoea, opioids, adaptive servoventilation, bilateral positive airway pressure and continuous positive airway pressure Year: 2010